Parsaclisib, an experimental oral therapy from Incyte, safely and effectively increased levels of hemoglobin in about half of people with cold agglutinin disease (CAD) in a small Phase 2 clinical trial, a study shows. Data from the study (NCT03538041), which included people with other forms of autoimmune…
News
Restarting Enjaymo (sutimlimab) after stopping it for up to four months was generally safe and brought blood markers of cold agglutinin disease (CAD) back to levels before its cessation. These are the findings of a Japanese open-label extension (OLE) study wherein seven CAD patients who completed one of…
Recordati agreed to acquire the global rights to Enjaymo (sutimlimab), the only approved targeted therapy for cold agglutinin disease (CAD), from Sanofi. “With a strong clinical profile and as the only product approved for the treatment of CAD, Enjaymo addresses a serious unmet medical need for patients…
Researchers have developed an artificial intelligence (AI)-based model designed to identify existing medicines that could be repurposed to treat rare conditions such as cold agglutinin disease (CAD). The model, called TxGNN, was able to identify possible therapeutic candidates for more than 17,000 conditions in a study, and researchers believe…
How childhood autoimmune hemolytic anemia (AIHA) — a group of rare conditions that includes cold agglutinin disease (CAD) — is defined and classified varies widely, as does the approach to care for children with hard-to-treat disease, a review study shows. “Standardized definitions and classifications are needed to guide collaborative efforts…
The detection of cold agglutinins, the self-reactive antibodies that drive cold agglutinin disease (CAD), was crucial for the correct diagnosis and management of anemia — lower than normal levels of red blood cells or hemoglobin — in a 37-year-old man with several traumatic injuries after a motorcycle accident, according…
In a young girl in India, cold agglutinin disease (CAD) secondary to a respiratory infection resulted in symptoms suggestive of vasculitis, a group of conditions marked by blood vessel inflammation, a study reported. The symptoms mimicking vasculitis included blueish-blackish discoloration of the nose’s tip that indicated tissue cell death…
Nearly 18% of people with autoimmune hemolytic anemia (AIHA), of which cold agglutinin disease (CAD) is one type, were hospitalized due to an infection within six months of their first rituximab infusion, according to a French study. Patients particularly at risk for infection-related hospitalizations were those older than…
A 50-year-old woman developed cold agglutinin disease (CAD) secondary to two different types of cancer within the thyroid gland, a study reported. The surgical removal of the thyroid gland successfully treated both the cancer and CAD. While CAD has been reported to occur secondary to blood cancers, it is…
A woman in Costa Rica developed cold agglutinin disease (CAD) secondary to a diagnosis of systemic lupus erythematosus (SLE) that was complicated by nephritis, a serious kidney inflammation that often occurs with this form of lupus. CAD “is exceptionally rare in SLE, with few cases being reported in…
Recent Posts
- With my health from CAD steadily declining, I call in the cavalry, part 2
- FDA fast-tracks potential new option for autoimmune blood diseases
- Long-term Enjaymo use shows favorable outcomes in CAD: Study
- With my health from CAD steadily declining, I call in the cavalry, part 1
- Genetic variations in underlying lymphoma influence AIHA types
- Lessons from ‘Winnie-the-Pooh’ help me navigate life with CAD
- Cost-effective rituximab-based treatment keeps CAD at bay for years
- This year, ongoing CAD symptoms dampened my holiday cheer
- Immunochemotherapy can help control CAD but it carries safety risks
- Oral therapy iptacopan eases anemia in CAD patients: Small trial